Literature DB >> 25778625

Endotoxin contamination of apolipoprotein A-I: effect on macrophage proliferation--a cautionary tale.

Xueting Jin1, Qing Xu1, Keith Champion2, Howard S Kruth3.   

Abstract

This technical report addresses the problem of endotoxin contamination of apolipoprotein reagents. Using a bromodeoxyuridine incorporation cell proliferation assay, we observed that human plasma ApoA-I as low as 1 μg/ml resulted in a >90% inhibition in macrophage proliferation. However, not all ApoA-I from different sources showed this effect. We considered the possibility that endotoxin contamination of the apolipoproteins contributed to the differential inhibition of macrophage cell proliferation. Endotoxin alone very potently inhibited macrophage proliferation (0.1 ng/ml inhibited macrophage proliferation>90%). Measurement of endotoxin levels in the apolipoprotein products, including an analysis of free versus total endotoxin, the latter which included endotoxin that was masked due to binding to protein, suggested that free endotoxin mediated inhibition of macrophage proliferation. Despite the use of an advanced endotoxin removal procedure and agents commonly used to inhibit endotoxin action, the potency of endotoxin precluded successful elimination of endotoxin effect. Our findings show that endotoxin contamination can significantly influence apparent apolipoprotein-mediated cell effects (or effects of any other biological products), especially when these products are tested on highly endotoxin-sensitive cells, such as macrophages. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Apolipoproteins; Atherosclerosis; Cell proliferation; Endotoxin; Macrophages

Mesh:

Substances:

Year:  2015        PMID: 25778625      PMCID: PMC4397170          DOI: 10.1016/j.atherosclerosis.2015.03.007

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  22 in total

Review 1.  Differences in lipopolysaccharide-induced signaling between conventional dendritic cells and macrophages.

Authors:  Ivan Zanoni; Francesca Granucci
Journal:  Immunobiology       Date:  2010-06-04       Impact factor: 3.144

2.  Contribution of the C-terminal end of apolipoprotein AI to neutralization of lipopolysaccharide endotoxic effect.

Authors:  María F Henning; Vanesa Herlax; Laura Bakás
Journal:  Innate Immun       Date:  2010-05-25       Impact factor: 2.680

3.  Lipopolysaccharide-stimulated nitric oxide production and inhibition of cell proliferation is antagonized by ethanol in a clonal macrophage cell line.

Authors:  C Y Chang; M Tucci; R C Baker
Journal:  Alcohol       Date:  2000-01       Impact factor: 2.405

4.  Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I.

Authors:  T Massamiri; P S Tobias; L K Curtiss
Journal:  J Lipid Res       Date:  1997-03       Impact factor: 5.922

5.  Quantification of the endotoxin-neutralizing capacity of serum and plasma.

Authors:  G H Zhang; L Baek; T Bertelsen; C Koch
Journal:  APMIS       Date:  1995-10       Impact factor: 3.205

6.  Interferon gamma induces the expression of p21waf-1 and arrests macrophage cell cycle, preventing induction of apoptosis.

Authors:  J Xaus; M Cardó; A F Valledor; C Soler; J Lloberas; A Celada
Journal:  Immunity       Date:  1999-07       Impact factor: 31.745

7.  Effect of anticoagulants on binding and neutralization of lipopolysaccharide by the peptide immunoglobulin conjugate CAP18(106-138)-immunoglobulin G in whole blood.

Authors:  M Ogata; M F Fletcher; M Kloczewiak; P M Loiselle; E M Zanzot; M W Vermeulen; H S Warren
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Commercially available recombinant sonic hedgehog up-regulates Ptc and modulates the cytokine and chemokine expression of human macrophages: an effect mediated by endotoxin contamination?

Authors:  Sonia J Wakelin; John L R Forsythe; O James Garden; Sarah E M Howie
Journal:  Immunobiology       Date:  2007-08-27       Impact factor: 3.144

9.  "Dirty little secrets"--endotoxin contamination of recombinant proteins.

Authors:  Sonia J Wakelin; Ian Sabroe; Christopher D Gregory; Ian R Poxton; John L R Forsythe; O James Garden; Sarah E M Howie
Journal:  Immunol Lett       Date:  2006-05-11       Impact factor: 3.685

10.  Contamination of nanoparticles by endotoxin: evaluation of different test methods.

Authors:  Stijn Smulders; Jean-Pierre Kaiser; Stefano Zuin; Kirsten L Van Landuyt; Luana Golanski; Jeroen Vanoirbeek; Peter Wick; Peter Hm Hoet
Journal:  Part Fibre Toxicol       Date:  2012-11-09       Impact factor: 9.400

View more
  7 in total

1.  Culture of Macrophage Colony-stimulating Factor Differentiated Human Monocyte-derived Macrophages.

Authors:  Xueting Jin; Howard S Kruth
Journal:  J Vis Exp       Date:  2016-06-30       Impact factor: 1.355

2.  High-density lipoprotein reduces inflammation from cholesterol crystals by inhibiting inflammasome activation.

Authors:  Seth G Thacker; Abdalrahman Zarzour; Ye Chen; Mustafa S Alcicek; Lita A Freeman; Dennis O Sviridov; Stephen J Demosky; Alan T Remaley
Journal:  Immunology       Date:  2016-08-28       Impact factor: 7.397

Review 3.  Making the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell Expansion.

Authors:  Carla Dessels; Marnie Potgieter; Michael S Pepper
Journal:  Front Cell Dev Biol       Date:  2016-10-17

4.  CD146 controls the quality of clinical grade mesenchymal stem cells from human dental pulp.

Authors:  Lan Ma; Zhiqing Huang; Di Wu; Xiaoxing Kou; Xueli Mao; Songtao Shi
Journal:  Stem Cell Res Ther       Date:  2021-08-30       Impact factor: 6.832

5.  Interactions of Bacterial Toxin CNF1 and Host JAK1/2 Driven by Liquid-Liquid Phase Separation Enhance Macrophage Polarization.

Authors:  Xuan Sun; Jianming Yang; Xueqin Deng; Yuting Wei; Changying Wang; Yaxiu Guo; Huan Yang; Liu Yang; Chunhui Miao; Junqiang Lv; Yawen Xiao; Hong Zhang; Zhi Yao; Quan Wang
Journal:  mBio       Date:  2022-06-29       Impact factor: 7.786

6.  Human serum and platelet lysate are appropriate xeno-free alternatives for clinical-grade production of human MuStem cell batches.

Authors:  Charlotte Saury; Aurélie Lardenois; Cindy Schleder; Isabelle Leroux; Blandine Lieubeau; Laurent David; Marine Charrier; Laëtitia Guével; Sabrina Viau; Bruno Delorme; Karl Rouger
Journal:  Stem Cell Res Ther       Date:  2018-05-02       Impact factor: 6.832

7.  A model study for the manufacture and validation of clinical-grade deciduous dental pulp stem cells for chronic liver fibrosis treatment.

Authors:  Tsuyoshi Iwanaka; Takayoshi Yamaza; Soichiro Sonoda; Koichiro Yoshimaru; Toshiharu Matsuura; Haruyoshi Yamaza; Shouichi Ohga; Yoshinao Oda; Tomoaki Taguchi
Journal:  Stem Cell Res Ther       Date:  2020-03-25       Impact factor: 6.832

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.